Shan Dong Kexing Bioproducts Co Ltd (688136)

Currency in CNY
33.68
+0.18(+0.54%)
Closed·
688136 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
33.4334.17
52 wk Range
16.3763.99
Key Statistics
Bid/Ask
33.66 / 33.68
Prev. Close
33.5
Open
33.76
Day's Range
33.43-34.17
52 wk Range
16.37-63.99
Volume
1.13M
Average Volume (3m)
4.38M
1-Year Change
95.91%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
688136 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
42.00
Upside
+24.70%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Shan Dong Kexing Bioproducts Co Ltd Company Profile

Kexing Biopharm Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia. The company focuses on oncology, immunology, and degenerative diseases; and develops new antibodies, proteins, nucleic acid drugs, and antiviral therapy, as well as for the treatment of tumor, autoimmune, metabolic diseases, and other therapeutic fields. It also develops GB05 human interferon a1b inhalation solution that is in Phase III clinical trial; GB-K02, an human granulocyte colony-stimulating factor injection in Phase III clinical trial; GB08, an growth hormone that has completed Phase I clinical trial; GB10 for fundus diseases; GB12 for atopic dermatitis; GB18 for cancer cachexia; GB23 for solid tumors; GB24 for inflammatory bowel diseases; and GB25, an tri-specific antibody for colorectal cancer. In addition, the company’s products include drugs, such as human erythropoietin, human interferon a1b and human granulocyte colony-stimulating factor injections, albumin-bound paclitaxel, infliximab injection, combined clostridium butyricum, and bifidobacterium powder/capsule. Kexing Biopharm Co., Ltd. was founded in 1997 and is based in Jinan, China.

Employees
947
Market
China

Compare 688136 to Peers and Sector

Metrics to compare
688136
Peers
Sector
Relationship
P/E Ratio
52.9x37.8x−0.6x
PEG Ratio
0.27−0.690.00
Price/Book
3.9x2.8x2.6x
Price / LTM Sales
4.4x7.7x3.3x
Upside (Analyst Target)
25.4%15.3%45.2%
Fair Value Upside
Unlock4.5%7.0%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 42.00
(+24.70% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.62%
Dividend Yield
0.24%
Industry Median 1.42%
Annualised payout
0.08
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Oct 30, 2025
EPS / Forecast
0.15 / --
Revenue / Forecast
447.17M / --
EPS Revisions
Last 90 days

688136 Income Statement

FAQ

What Stock Exchange Does Shan Dong Kexing Bioproducts Co Trade On?

Shan Dong Kexing Bioproducts Co is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Shan Dong Kexing Bioproducts Co?

The stock symbol for Shan Dong Kexing Bioproducts Co is "688136."

What Is the Shan Dong Kexing Bioproducts Co Market Cap?

As of today, Shan Dong Kexing Bioproducts Co market cap is 6.64B.

What Is Shan Dong Kexing Bioproducts Co's Earnings Per Share (TTM)?

The Shan Dong Kexing Bioproducts Co EPS (TTM) is 0.62.

When Is the Next Shan Dong Kexing Bioproducts Co Earnings Date?

Shan Dong Kexing Bioproducts Co will release its next earnings report on 29 Oct 2025.

From a Technical Analysis Perspective, Is 688136 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Shan Dong Kexing Bioproducts Co Stock Split?

Shan Dong Kexing Bioproducts Co has split 0 times.

How Many Employees Does Shan Dong Kexing Bioproducts Co Have?

Shan Dong Kexing Bioproducts Co has 947 employees.

What is the current trading status of Shan Dong Kexing Bioproducts Co (688136)?

As of 20 Nov 2025, Shan Dong Kexing Bioproducts Co (688136) is trading at a price of 33.68, with a previous close of 33.50. The stock has fluctuated within a day range of 33.43 to 34.17, while its 52-week range spans from 16.37 to 63.99.

What Is Shan Dong Kexing Bioproducts Co (688136) Price Target According to Analysts?

The average 12-month price target for Shan Dong Kexing Bioproducts Co is CNY42, with a high estimate of CNY42 and a low estimate of CNY42. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.70% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.